Fabio
74 lines
2.7 KiB
Markdown
74 lines
2.7 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Relates to prohibiting co-payments for treatment at an opioid treatment program"
|
||
description: "Relates to prohibiting insurance companies from imposing co-payments for treatment at an opioid treatment program."
|
||
jurisdiction: "us/states/ny"
|
||
legislature: "New York Legislature"
|
||
session: "2021-2022"
|
||
identifier: "A 372"
|
||
citation: "New York A 372 (2021-2022)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["ROSENTHAL L"]
|
||
version_count: 1
|
||
action_count: 16
|
||
vote_count: 2
|
||
first_action: "2021-01-06"
|
||
last_action: "2022-12-23"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/4fbcb5a8-ddfc-44ad-a974-ccf07f07979e"
|
||
source_url: "http://www.nysenate.gov/legislation/bills/2021/A372"
|
||
source_hash: "c74bea49d016e52c907d004b722bc75c3b6038699b2b5f63b57b052b53c18c2b"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-ny"]
|
||
---
|
||
|
||
# New York A 372 (2021-2022) — Relates to prohibiting co-payments for treatment at an opioid treatment program
|
||
|
||
Relates to prohibiting insurance companies from imposing co-payments for treatment at an opioid treatment program.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **A372** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=A372&term=2021&Text=Y)
|
||
|
||
## Votes
|
||
|
||
- Assembly Vote — **143–1** (pass) · lower
|
||
- Floor Vote — **57–4** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- ROSENTHAL L — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2021-01-06** REFERRED TO INSURANCE `referral-committee`
|
||
- **2021-05-20** REPORTED REFERRED TO CODES `referral-committee`
|
||
- **2021-05-25** REPORTED REFERRED TO RULES `referral-committee`
|
||
- **2021-06-01** REPORTED
|
||
- **2021-06-01** RULES REPORT CAL.156
|
||
- **2021-06-01** ORDERED TO THIRD READING RULES CAL.156
|
||
- **2022-01-05** ORDERED TO THIRD READING CAL.27
|
||
- **2022-01-11** PASSED ASSEMBLY `passage`
|
||
- **2022-01-11** DELIVERED TO SENATE
|
||
- **2022-01-11** REFERRED TO INSURANCE `referral-committee`
|
||
- **2022-05-25** SUBSTITUTED FOR S5690
|
||
- **2022-05-25** 3RD READING CAL.763
|
||
- **2022-05-25** PASSED SENATE `passage`
|
||
- **2022-05-25** RETURNED TO ASSEMBLY
|
||
- **2022-12-12** DELIVERED TO GOVERNOR `executive-receipt`
|
||
- **2022-12-23** SIGNED CHAP.734 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/4fbcb5a8-ddfc-44ad-a974-ccf07f07979e`. Confidence: reported (aggregated from official New York legislature records).
|
||
|